Pfizer ships out 2 cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO March 25, 2021
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates March 25, 2021
Pyxis Oncology Appoints Pharmaceutical Industry Veteran Ronald Herbst, PhD, as Chief Scientific Officer October 16, 2019
